JP2003277288A5 - - Google Patents

Download PDF

Info

Publication number
JP2003277288A5
JP2003277288A5 JP2002376903A JP2002376903A JP2003277288A5 JP 2003277288 A5 JP2003277288 A5 JP 2003277288A5 JP 2002376903 A JP2002376903 A JP 2002376903A JP 2002376903 A JP2002376903 A JP 2002376903A JP 2003277288 A5 JP2003277288 A5 JP 2003277288A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
same
cancer
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002376903A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003277288A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2002376903A priority Critical patent/JP2003277288A/ja
Priority claimed from JP2002376903A external-priority patent/JP2003277288A/ja
Publication of JP2003277288A publication Critical patent/JP2003277288A/ja
Publication of JP2003277288A5 publication Critical patent/JP2003277288A5/ja
Pending legal-status Critical Current

Links

JP2002376903A 2001-12-27 2002-12-26 がんの予防・治療剤 Pending JP2003277288A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002376903A JP2003277288A (ja) 2001-12-27 2002-12-26 がんの予防・治療剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001398220 2001-12-27
JP2001-398220 2001-12-27
JP2002376903A JP2003277288A (ja) 2001-12-27 2002-12-26 がんの予防・治療剤

Publications (2)

Publication Number Publication Date
JP2003277288A JP2003277288A (ja) 2003-10-02
JP2003277288A5 true JP2003277288A5 (de) 2006-02-02

Family

ID=29252844

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002376903A Pending JP2003277288A (ja) 2001-12-27 2002-12-26 がんの予防・治療剤

Country Status (1)

Country Link
JP (1) JP2003277288A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6064231B2 (ja) * 2011-06-03 2017-01-25 オンコセラピー・サイエンス株式会社 がん治療および診断のための標的遺伝子としてのｓｕｖ３９ｈ２

Similar Documents

Publication Publication Date Title
MX364100B (es) Péptidos protectores de tejido y sus usos.
EP1999149A4 (de) Anti-igf-ir-antikörper und ihre verwendung
WO2003016475A3 (en) Nucleic acid and amino acid sequences involved in pain
WO2004006838A3 (en) Novel kinases
WO2001055178A3 (en) Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer
JP2006158399A5 (ja) 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤
WO2002061076A1 (en) Adiponectin-associated protein
EP2114431A4 (de) Zusammensetzung mit arazym zur prävention und behandlung von krebs
MXPA02008239A (es) Gen humano de la esquizofrenia.
HK1145290A1 (en) Oxidized avidin with high residency time in the treated tissues
WO2003105773A3 (en) MUTATIONS OF PDGFRA ACTIVATED AS DIAGNOSTIC MARKERS AND THERAPEUTIC TARGETS
HK1052026A1 (en) Human enzymes of the metalloprotease family
JP2003277288A5 (de)
JP2003277289A5 (de)
DE69924877D1 (en) Humanes akt-3 protein
EP1282641A4 (de) MENSCHLICHES, GEBäRMUTTERKREBS-SPEZIFISCHES SUPPRESSORPROTEIN, FüR DAS PROTEIN KODIERES POLYNUKLEOTID, MIT DEM POLYNUKLEOTID TRANSFORMIERTE ZELLE UND VERFAHREN ZUR UNTERDRüCKUNG DER PROLIFERATION VON KREBSZELLEN UNTER VERWENDUNG DES EXPRESSIONSVEKTORS
EP1666880A4 (de) Screening-verfahren
WO2005023186A3 (en) Methods of identifying agents that inhibit the growth of cancer cells
TW200517125A (en) Pharmaceutical composition for treatment of solid cancers
EP1669451A4 (de) Hirntumormarker und verfahren zur hirntumordiagnose
WO2002070559A3 (en) Nuclear hormone receptor ligand binding domains
EP1760087A4 (de) Neuer proteinkomplex und anwendungen davon
JP2005513000A5 (de)
JP2002355060A5 (de)
JP2007517775A5 (de)